Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 1
2006 2
2007 6
2008 7
2009 11
2010 11
2011 11
2012 9
2013 16
2014 10
2015 14
2016 24
2017 26
2018 23
2019 17
2020 31
2021 43
2022 27
2023 26
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. Among authors: yamamoto m. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction Model.
Khan JM, Kamioka N, Lisko JC, Perdoncin E, Zhang C, Maini A, Chen M, Li Y, Ludwig S, Westermann D, Amat Santos IJ, Kalińczuk Ł, Sinning JM, Kawaguchi T, Fuku Y, Cheema AN, Félix-Oliveira A, Yamamoto M, Kagase A, Codner P, Valle RD, Iyer VS, Kim HS, Lin MS, Maini B, Rodriguez R, Montorfano M, Ancona MB, Tada N, Miyasaka M, Ahmad H, Ruggiero NJ, Torguson R, Ben-Dor I, Shults CC, Weissman G, Lederman RJ, Greenbaum AB, Babaliaros VC, Waksman R, Rogers T. Khan JM, et al. Among authors: yamamoto m. JACC Cardiovasc Interv. 2023 Feb 27;16(4):415-425. doi: 10.1016/j.jcin.2022.11.018. JACC Cardiovasc Interv. 2023. PMID: 36858660 Free PMC article.
Transcatheter aortic valve implantation and frailty.
Shimura T, Yamamoto M; OCEAN-SHD family. Shimura T, et al. Among authors: yamamoto m. Cardiovasc Interv Ther. 2022 Oct;37(4):626-634. doi: 10.1007/s12928-022-00868-w. Epub 2022 Jul 29. Cardiovasc Interv Ther. 2022. PMID: 35904717 Review.
No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
Kobari Y, Inohara T, Tsuruta H, Yashima F, Shimizu H, Fukuda K, Naganuma T, Mizutani K, Yamawaki M, Tada N, Yamanaka F, Shirai S, Tabata M, Ueno H, Takagi K, Watanabe Y, Yamamoto M, Hayashida K. Kobari Y, et al. Among authors: yamamoto m. JACC Cardiovasc Interv. 2023 Jan 9;16(1):79-91. doi: 10.1016/j.jcin.2022.10.010. Epub 2022 Dec 14. JACC Cardiovasc Interv. 2023. PMID: 36599591
Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation.
Yamamoto M, Hayashida K, Hengstenberg C, Watanabe Y, Van Mieghem NM, Jin J, Saito S, Valgimigli M, Nicolas J, Mehran R, Moreno R, Kimura T, Chen C, Unverdorben M, Dangas GD. Yamamoto M, et al. Am J Cardiol. 2023 Nov 15;207:150-158. doi: 10.1016/j.amjcard.2023.08.067. Epub 2023 Sep 21. Am J Cardiol. 2023. PMID: 37741105 Free article. Clinical Trial.
Vascular management during transcatheter aortic valve replacement.
Tokuda T, Yamamoto M; OCEAN-SHD investigators. Tokuda T, et al. Among authors: yamamoto m. Cardiovasc Interv Ther. 2023 Jan;38(1):18-27. doi: 10.1007/s12928-022-00900-z. Epub 2022 Nov 29. Cardiovasc Interv Ther. 2023. PMID: 36447120 Review.
Chronic kidney disease and transcatheter aortic valve implantation.
Adachi Y, Yamamoto M; OCEAN-SHD family. Adachi Y, et al. Among authors: yamamoto m. Cardiovasc Interv Ther. 2022 Jul;37(3):458-464. doi: 10.1007/s12928-022-00859-x. Epub 2022 May 5. Cardiovasc Interv Ther. 2022. PMID: 35511340 Review.
Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve Replacement.
Miyamoto J, Ohno Y, Kamioka N, Ikari Y, Otsuka T, Tada N, Naganuma T, Yamawaki M, Yamanaka F, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Watanabe Y, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators. Miyamoto J, et al. Among authors: yamamoto m. J Am Coll Cardiol. 2022 Oct 25;80(17):1601-1613. doi: 10.1016/j.jacc.2022.08.757. J Am Coll Cardiol. 2022. PMID: 36265955 Free article.
Short-Term Outcomes Following Transcatheter Edge-to-Edge Repair: Insights From the OCEAN-Mitral Registry.
Saji M, Yamamoto M, Kubo S, Asami M, Enta Y, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Yamaguchi J, Nakajima Y, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Adachi Y, Otsuka T, Hayashida K; OCEAN-Mitral Investigators. Saji M, et al. Among authors: yamamoto m. JACC Asia. 2023 Aug 29;3(5):766-773. doi: 10.1016/j.jacasi.2023.06.008. eCollection 2023 Oct. JACC Asia. 2023. PMID: 38094997 Free PMC article.
Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) Trial.
Inohara T, Otsuka T, Watanabe Y, Shirai S, Tada N, Yamanaka F, Ueno H, Ohno Y, Tabata M, Suzuyama H, Asami M, Yamawaki M, Izumo M, Yamasaki K, Nishina H, Fuku Y, Mizutani K, Yashima F, Yamamoto M, Hayashida K. Inohara T, et al. Among authors: yamamoto m. Contemp Clin Trials. 2023 Nov;134:107358. doi: 10.1016/j.cct.2023.107358. Epub 2023 Oct 16. Contemp Clin Trials. 2023. PMID: 37852534 Clinical Trial.
265 results